DAY 2 Friday, March 6, 2020 LS : Luncheon Seminar SS ...Satoshi Iyama Oral Session 24 Rehabilitation...

DAY 2 Friday, March 6, 202021:3020:0019:0018:0017:0016:0015:0014:0013:0012:0011:0010:009:008:007:30

Glass Building

Hall EHall Building

Tokyo International Forum

Room14FHall C

Room27F

Hall B7（1）

Room37F

Hall B7（2）

Room45F

Hall B5

Room57F

Hall D7

Room65F

Hall D5

Room71F

Hall D1

Room85FG502

Room95FG510

Room104FG402

Room114FG409

Room126FG602

PosterB2F

ExhibitionB2F

: English EL : Educational LectureLS : Luncheon Seminar SS : Sweets SeminarE

17:15～18:008:30～10:00

9:00～18:00

10:00～17:15

9:00～10:00 10:10～11:10

9:00～10:00 10:10～11:10

9:00～10:00 10:10～11:10

9:00～10:00 10:10～11:10

10:10～10:58

10:20～11:08

9:00～10:00

9:00～9:48

9:00～10:12

10:10～11:22

13:25～14:37

13:30～14:30 14:40～15:40

13:30～14:30 14:40～15:40

13:30～14:30 14:40～15:28

14:50～15:50

13:30～14:42 14:50～16:02

13:30～14:42

13:30～14:42

9:00～10:00 13:45～14:4510:10～11:10

13:50～14:30 14:40～15:55

14:40～15:55

Reception19:30～21:30

9:00～11:00 13:45～15:15

9:00～10:30

9:00～10:30

13:30～14:40 14:45～16:0010:40～11:10

18:30～13:00～13:45

11:30～12:20 16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

12:35～13:00

9:00～9:30 9:35～10:05 10:10～10:40 10:45～11:15 13:30～14:00 14:05～14:35 14:40～15:10 15:15～15:45

MiniConcert

14:55～15:55

18:00～18:30

14:50～16:02

Oral Session 1Transplant Source 1Yasuyuki Arai

Oral Session 2Transplant Source 2Yoshihiro Inamoto

Oral Session 16Viral Infection 1Takanobu Morishita

Oral Session 17Viral Infection 2Akihiro Yokoyama

Oral Session 20LTFU/QOLYasuyuki Inoue

Oral Session 21ImmunizationSatoshi Iyama

Oral Session 24Rehabilitation 1

Eisei Kondo

Oral Session 25Rehabilitation 2Hiroya Tamaki

Oral Session 9GVHD/GVL 2Kazutaka Ozeki

Oral Session 13Early Complication(Engraftment Failure)Satoshi Nishiwaki

Oral Session 4Conditioning 1Naomi Kawashima

Oral Session 8GVHD/GVL 1Hiroaki Shimizu

Oral Session 12Early Complication(TMA/SOS)Takahiko Nakane

Oral Session 5Conditioning 2Shigeru Kusumoto

Oral Session 3Transplant Source 3

Ayako Arai

Oral Session 10GVHD/GVL 3Tomomi Toubai

Oral Session 11GVHD/GVL 4Tatsunori Goto

Oral Session 18Immunotherapy/Cell Therapy 1Kazuhiko Ikeda

Oral Session 19Immunotherapy/Cell Therapy 2Shinichi Kako

Oral Session 22Nutrition

Management 1Shigeo Fuji

Oral Session 23Nutrition

Management 2Sachiko Seo

Oral Session 27Histocompatibility

AntigenIlseung Choi

Oral Session 6Immune ReconstitutionShingo Kurahashi

Oral Session 7TDM/DrugsTakuro Nishikawa

Oral Session 14Early Complication(Pretransplant Evaluation/Others)Hisayuki Yokoyama

Oral Session 26Management/Care/Team Medical-care

Taku Kikuchi

Oral Session 15Early Complication(Heart/Lungs/Central Nervous System)Kentaro Fukushima

Oral Sessionfor Nurse 1

Transplant NursingYumiko Kiso Yuko Shimizu

Oral Sessionfor Nurse 2LTFU/QOLKazuyo YoshikawaRei Yamaoka　　

The allied organizations forumfor promoting hematopoieticstem cell transplantation

【Live Video】The forum of allied organizationspromoting hematopoietic stemcell transplantation (HSCT)

Symposium 1Recent advances in genomicsand genome-engineering inHematology/OncologyKoichi Akashi, Seishi Ogawa

SpecialPlanning 1Minoko TakahashiShuichi Taniguchi

Nursing EducationalLecture 1

Speaker: Yuka OzasaChair: Kazue Mori　　

Nursing EducationalLecture 2

Speaker: Sanae TakanashiChair: Megumi Fujisawa

OpeningCeremony

EL1Speaker: Nobuhiro TsukadaChair: Chiaki Nakaseko

EL2Speaker: Tomohiro MorioChair: Yoshiyuki Takahashi

EL3Speaker: Hiroki YamaguchiChair: Fumihiko Ishikawa

EL4Speaker: Gou YamamotoChair: Koji Idutsu

EL5Speaker: Atsushi KikutaChair: Takahiro Fukuda

EL6Speaker: Atsushi ManabeChair: Masami Inoue

EL7Speaker: Hiroshi KimuraChair: Kimikazu Matsumoto

EL8Speaker: Takahiro MaedaChair: Seishi Ogawa

PosterPresentationPoster mounting Poster viewing

Exhibition

E

E

E

Symposium 2Cord Blood Transplantation

in Future Satoshi Takahashi, Shuichi Taniguchi

Current Seminar 1Koji NagafujiTakahiro Fukuda

HCTC WorkshopShinichiro Mori, Yuka Nagai

Workshop 1Yuichiro NawaYoshikiyo Ito

Workshop 2Takehiko MoriYoshihiko Soga

CurrentSeminar 2Akihiro Shimosaka

E

LS1The importance of oral supportive care for

hematopoietic stem cell transplantation recipients - to fulfill our responsibility for life

Speaker: Yoshihiko SogaChair: Maki Yokota

（Chugai Pharmaceutical Co., Ltd）

SS1High-dose chemotherapy in pediatric malignant solid tumorSpeaker: Fuminori Iwasaki Maki Taduke

Chair: Masami Inoue Tomoko Fukuchi

（Sumitomo Dainippon Pharma Co., Ltd.）

SS2Pathophysiology and immune-targeted therapeutic approach of multiple myeloma in 2020Speaker: Junya KurodaChair: Kazutaka Sunami（Bristol-Myers Squibb K.K.）

SS3Multiple Myeloma 2020:

Management of the Newly Diagnosed Transplant Eligible Patient

Speaker: Jonathan L. KaufmanChair: Hideo Harigae

（Janssen Pharmaceutical K.K.）

SS4Statistical analyses of stem cell transplantation data using EZR (Easy R)

Speaker: Yoshinobu KandaChair: Satoshi Takahashi

（Fuji Pharma Co., Ltd.）

SS5New treatment strategy for myelofibrosis

Speaker: Shinsuke Takagi Masahiro TakeuchiChair: Nobuyuki Aotsuka

（Novartis Pharma K.K.）

SS6Key points for the introduction of the BCL-2 inhibitor VenclextaSpeaker: Tomoki Ito Noriko YokotaChair: Takanori Teshima

Ayako Mori（AbbVie GK）

SS7Overcoming challenges of refractory AML

-Current situations and the future prospect including FLT3 inhibitors-

Speaker: Naoyuki UchidaChair: Kouichi Akashi

（Astellas Pharma Inc.）

SS8Intravenous Access to Hematopoietic

Stem Cell Transplantation -Usefulness of PICC

Speaker: Yasuyuki AraiChair: Yoshinobu Maeda（Nippon Becton Dickinson

Company,Ltd.）

SS9Current status and future perspective

of conditioning regimen for allogeneic stem cell transplantationSpeaker: Hisashi YamamotoChair: Masashi Sawa

（Otsuka Pharmaceutical Co.,LTD.）

SS10Management and follow-up after hematopoietic stem cell transplantation

Speaker: Ryoji Kobayashi Hideki AraokaChair: Sakiko Kondo

（Novartis Pharma K.K.）

LS2Daratumumab treatment for multiple myeloma

Speaker: Kazutaka SunamiChair: Tatsuo Ichinohe

（Janssen Pharmaceutical K.K.）

LS3Practice of relapsed/refractory acute lymphoblastic leukemia treatment in our hospital

Speaker: Noriko DokiChair: Yosuke Minami（Pfizer Japan Inc.）

LS4Brand new strategy for

IFI management in evolving hematology malignancy treatment approach

Speaker: Toshihiro MiyamotoChair: Takanori Teshima（MSD K.K.）

LS5MSC for GVHD

Speaker: Jun Kato Motohiro KatoChair: Koichi Miyamura

（JCR Pharmaceuticals Co., Ltd.）

LS6New aspects of antifungal

management after hematopoietic stem cell transplantationSpeaker: Yuki MoriChair: Makoto Murata（Sumitomo Dainippon Pharma Co., Ltd.）

LS7Novel therapeutic strategy

for relapsed/refractory AML

Speaker: Takahiro YamauchiChair: Yasushi Miyazaki

（DAIICHI SANKYO COMPANY, LIMITED）

LS8Factors predicting

outcome after allogeneic HSCT for myelofibrosisSpeaker: Yasuharu Hamano

Chair: Shingo Yano（MOCHIDA PHARMACEUTICAL CO.,LTD）

LS9Management of cytomegalovirus infection in the Reiwa era.

-Choosing wisely-Speaker: Yoshinobu KandaChair: Takehiko Mori

（Mitsubishi Tanabe Pharma Corporation）

LS10Update on treatment and diagnosis of GVHDSpeaker: Yoshihiro InamotoChair: Yoshinobu Maeda（Novartis Pharma K.K.）

LS11Optimizing stem cell mobilization

in the era of plerixaforSpeaker: Nobuhiro TsukadaChair: Masahiro Kizaki（Sanofi K.K.）

Bruch up onLTFU NurseSayaka HonmaHitomi Nishimoto

P-001～P-009 Stem Cell Mobilization and CollectionP-011～P-015 Transplant SourceP-017～P-023 ConditioningP-025～P-047 Transplant ImmunityP-049～P-053 Immunotherapy/Cell TherapyP-055 Child-specific Transplant DiseaseP-057～P-099 Transplant OutcomesP-101～P-117 Malignant Lymphoma/ATLP-119～P-133 Minimal Residual Disease and RecurrenceP-135～P-145 Early ComplicationP-147～P-183 Late ComplicationP-185～P-193 Bacterial InfectionP-195～P-213 Viral InfectionP-215～P-227 Fungal Infection/Other InfectionP-229～P-231 LTFU/QOLP-233～P-235 Marrow Donor Program/Cord Blood Bank/DonorsP-237 Hematopoietic Cell Transplant Coordinator and CoordinateP-239～P-249 Management/Care/Team Medical-careP-251～P-267 RehabilitationP-269～P-275 TDM/Drugs

Poster Presentation

NurseP1-01～P1-12 CareNurseP1-13～P1-14 Infection controlNurseP1-15～P1-22 Follow-upNurseP1-23～P1-27 Decision supportNurseP1-28 Team approachNurseP1-29～P1-32 Nursing Management, Education

Nursing Poster Presentation

Posterremoval

E

P.7 P.7 P.8 P.8 P.8 P.8 P.9 P.9

P.21 P.23

P.37 P.38

P.41 P.42

P.45 P.46

P.30

P.34

P.25

P.29

P.33

P.26

P.24

P.31 P.32

P.39 P.40

P.43 P.44

P.48

P.27 P.28

P.35

P.47

P.36

P.4 P.4P.80

P.81 P.10

P.3 P.4

P.5

P.9

P.6 P.7P.6

P.3

P.83

P.5

DAY 2 Friday, March 6, 202021:3020:0019:0018:0017:0016:0015:0014:0013:0012:0011:0010:009:008:007:30

Glass Building

Hall EHall Building

Tokyo International Forum

Room14FHall C

Room27F

Hall B7（1）

Room37F

Hall B7（2）

Room45F

Hall B5

Room57F

Hall D7

Room65F

Hall D5

Room71F

Hall D1

Room85FG502

Room95FG510

Room104FG402

Room114FG409

Room126FG602

PosterB2F

ExhibitionB2F

: English EL : Educational LectureLS : Luncheon Seminar SS : Sweets SeminarE

17:15～18:008:30～10:00

9:00～18:00

10:00～17:15

9:00～10:00 10:10～11:10

9:00～10:00 10:10～11:10

9:00～10:00 10:10～11:10

9:00～10:00 10:10～11:10

10:10～10:58

10:20～11:08

9:00～10:00

9:00～9:48

9:00～10:12

10:10～11:22

13:25～14:37

13:30～14:30 14:40～15:40

13:30～14:30 14:40～15:40

13:30～14:30 14:40～15:28

14:50～15:50

13:30～14:42 14:50～16:02

13:30～14:42

13:30～14:42

9:00～10:00 13:45～14:4510:10～11:10

13:50～14:30 14:40～15:55

14:40～15:55

Reception19:30～21:30

9:00～11:00 13:45～15:15

9:00～10:30

9:00～10:30

13:30～14:40 14:45～16:0010:40～11:10

18:30～13:00～13:45

11:30～12:20 16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

16:10～17:00

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

11:30～12:20

12:35～13:00

9:00～9:30 9:35～10:05 10:10～10:40 10:45～11:15 13:30～14:00 14:05～14:35 14:40～15:10 15:15～15:45

MiniConcert

14:55～15:55

18:00～18:30

14:50～16:02

Oral Session 1Transplant Source 1Yasuyuki Arai

Oral Session 2Transplant Source 2Yoshihiro Inamoto

Oral Session 16Viral Infection 1Takanobu Morishita

Oral Session 17Viral Infection 2Akihiro Yokoyama

Oral Session 20LTFU/QOLYasuyuki Inoue

Oral Session 21ImmunizationSatoshi Iyama

Oral Session 24Rehabilitation 1

Eisei Kondo

Oral Session 25Rehabilitation 2Hiroya Tamaki

Oral Session 9GVHD/GVL 2Kazutaka Ozeki

Oral Session 13Early Complication(Engraftment Failure)Satoshi Nishiwaki

Oral Session 4Conditioning 1Naomi Kawashima

Oral Session 8GVHD/GVL 1Hiroaki Shimizu

Oral Session 12Early Complication(TMA/SOS)Takahiko Nakane

Oral Session 5Conditioning 2Shigeru Kusumoto

Oral Session 3Transplant Source 3

Ayako Arai

Oral Session 10GVHD/GVL 3Tomomi Toubai

Oral Session 11GVHD/GVL 4Tatsunori Goto

Oral Session 18Immunotherapy/Cell Therapy 1Kazuhiko Ikeda

Oral Session 19Immunotherapy/Cell Therapy 2Shinichi Kako

Oral Session 22Nutrition

Management 1Shigeo Fuji

Oral Session 23Nutrition

Management 2Sachiko Seo

Oral Session 27Histocompatibility

AntigenIlseung Choi

Oral Session 6Immune ReconstitutionShingo Kurahashi

Oral Session 7TDM/DrugsTakuro Nishikawa

Oral Session 14Early Complication(Pretransplant Evaluation/Others)Hisayuki Yokoyama

Oral Session 26Management/Care/Team Medical-care

Taku Kikuchi

Oral Session 15Early Complication(Heart/Lungs/Central Nervous System)Kentaro Fukushima

Oral Sessionfor Nurse 1

Transplant NursingYumiko Kiso Yuko Shimizu

Oral Sessionfor Nurse 2LTFU/QOLKazuyo YoshikawaRei Yamaoka　　

The allied organizations forumfor promoting hematopoieticstem cell transplantation

【Live Video】The forum of allied organizationspromoting hematopoietic stemcell transplantation (HSCT)

Symposium 1Recent advances in genomicsand genome-engineering inHematology/OncologyKoichi Akashi, Seishi Ogawa

SpecialPlanning 1Minoko TakahashiShuichi Taniguchi

Nursing EducationalLecture 1

Speaker: Yuka OzasaChair: Kazue Mori　　

Nursing EducationalLecture 2

Speaker: Sanae TakanashiChair: Megumi Fujisawa

OpeningCeremony

EL1Speaker: Nobuhiro TsukadaChair: Chiaki Nakaseko

EL2Speaker: Tomohiro MorioChair: Yoshiyuki Takahashi

EL3Speaker: Hiroki YamaguchiChair: Fumihiko Ishikawa

EL4Speaker: Gou YamamotoChair: Koji Idutsu

EL5Speaker: Atsushi KikutaChair: Takahiro Fukuda

EL6Speaker: Atsushi ManabeChair: Masami Inoue

EL7Speaker: Hiroshi KimuraChair: Kimikazu Matsumoto

EL8Speaker: Takahiro MaedaChair: Seishi Ogawa

PosterPresentationPoster mounting Poster viewing

Exhibition

E

E

E

Symposium 2Cord Blood Transplantation

in Future Satoshi Takahashi, Shuichi Taniguchi

Current Seminar 1Koji NagafujiTakahiro Fukuda

HCTC WorkshopShinichiro Mori, Yuka Nagai

Workshop 1Yuichiro NawaYoshikiyo Ito

Workshop 2Takehiko MoriYoshihiko Soga

CurrentSeminar 2Akihiro Shimosaka

E

LS1The importance of oral supportive care for

hematopoietic stem cell transplantation recipients - to fulfill our responsibility for life

Speaker: Yoshihiko SogaChair: Maki Yokota

（Chugai Pharmaceutical Co., Ltd）

SS1High-dose chemotherapy in pediatric malignant solid tumorSpeaker: Fuminori Iwasaki Maki Taduke

Chair: Masami Inoue Tomoko Fukuchi

（Sumitomo Dainippon Pharma Co., Ltd.）

SS2Pathophysiology and immune-targeted therapeutic approach of multiple myeloma in 2020Speaker: Junya KurodaChair: Kazutaka Sunami（Bristol-Myers Squibb K.K.）

SS3Multiple Myeloma 2020:

Management of the Newly Diagnosed Transplant Eligible Patient

Speaker: Jonathan L. KaufmanChair: Hideo Harigae

（Janssen Pharmaceutical K.K.）

SS4Statistical analyses of stem cell transplantation data using EZR (Easy R)

Speaker: Yoshinobu KandaChair: Satoshi Takahashi

（Fuji Pharma Co., Ltd.）

SS5New treatment strategy for myelofibrosis

Speaker: Shinsuke Takagi Masahiro TakeuchiChair: Nobuyuki Aotsuka

（Novartis Pharma K.K.）

SS6Key points for the introduction of the BCL-2 inhibitor VenclextaSpeaker: Tomoki Ito Noriko YokotaChair: Takanori Teshima

Ayako Mori（AbbVie GK）

SS7Overcoming challenges of refractory AML

-Current situations and the future prospect including FLT3 inhibitors-

Speaker: Naoyuki UchidaChair: Kouichi Akashi

（Astellas Pharma Inc.）

SS8Intravenous Access to Hematopoietic

Stem Cell Transplantation -Usefulness of PICC

Speaker: Yasuyuki AraiChair: Yoshinobu Maeda（Nippon Becton Dickinson

Company,Ltd.）

SS9Current status and future perspective

of conditioning regimen for allogeneic stem cell transplantationSpeaker: Hisashi YamamotoChair: Masashi Sawa

（Otsuka Pharmaceutical Co.,LTD.）

SS10Management and follow-up after hematopoietic stem cell transplantation

Speaker: Ryoji Kobayashi Hideki AraokaChair: Sakiko Kondo

（Novartis Pharma K.K.）

LS2Daratumumab treatment for multiple myeloma

Speaker: Kazutaka SunamiChair: Tatsuo Ichinohe

（Janssen Pharmaceutical K.K.）

LS3Practice of relapsed/refractory acute lymphoblastic leukemia treatment in our hospital

Speaker: Noriko DokiChair: Yosuke Minami（Pfizer Japan Inc.）

LS4Brand new strategy for

IFI management in evolving hematology malignancy treatment approach

Speaker: Toshihiro MiyamotoChair: Takanori Teshima（MSD K.K.）

LS5MSC for GVHD

Speaker: Jun Kato Motohiro KatoChair: Koichi Miyamura

（JCR Pharmaceuticals Co., Ltd.）

LS6New aspects of antifungal

management after hematopoietic stem cell transplantationSpeaker: Yuki MoriChair: Makoto Murata（Sumitomo Dainippon Pharma Co., Ltd.）

LS7Novel therapeutic strategy

for relapsed/refractory AML

Speaker: Takahiro YamauchiChair: Yasushi Miyazaki

（DAIICHI SANKYO COMPANY, LIMITED）

LS8Factors predicting

outcome after allogeneic HSCT for myelofibrosisSpeaker: Yasuharu Hamano

Chair: Shingo Yano（MOCHIDA PHARMACEUTICAL CO.,LTD）

LS9Management of cytomegalovirus infection in the Reiwa era.

-Choosing wisely-Speaker: Yoshinobu KandaChair: Takehiko Mori

（Mitsubishi Tanabe Pharma Corporation）

LS10Update on treatment and diagnosis of GVHDSpeaker: Yoshihiro InamotoChair: Yoshinobu Maeda（Novartis Pharma K.K.）

LS11Optimizing stem cell mobilization

in the era of plerixaforSpeaker: Nobuhiro TsukadaChair: Masahiro Kizaki（Sanofi K.K.）

Bruch up onLTFU NurseSayaka HonmaHitomi Nishimoto

P-001～P-009 Stem Cell Mobilization and CollectionP-011～P-015 Transplant SourceP-017～P-023 ConditioningP-025～P-047 Transplant ImmunityP-049～P-053 Immunotherapy/Cell TherapyP-055 Child-specific Transplant DiseaseP-057～P-099 Transplant OutcomesP-101～P-117 Malignant Lymphoma/ATLP-119～P-133 Minimal Residual Disease and RecurrenceP-135～P-145 Early ComplicationP-147～P-183 Late ComplicationP-185～P-193 Bacterial InfectionP-195～P-213 Viral InfectionP-215～P-227 Fungal Infection/Other InfectionP-229～P-231 LTFU/QOLP-233～P-235 Marrow Donor Program/Cord Blood Bank/DonorsP-237 Hematopoietic Cell Transplant Coordinator and CoordinateP-239～P-249 Management/Care/Team Medical-careP-251～P-267 RehabilitationP-269～P-275 TDM/Drugs

Poster Presentation

NurseP1-01～P1-12 CareNurseP1-13～P1-14 Infection controlNurseP1-15～P1-22 Follow-upNurseP1-23～P1-27 Decision supportNurseP1-28 Team approachNurseP1-29～P1-32 Nursing Management, Education

Nursing Poster Presentation

Posterremoval

E

P.7 P.7 P.8 P.8 P.8 P.8 P.9 P.9

P.21 P.23

P.37 P.38

P.41 P.42

P.45 P.46

P.30

P.34

P.25

P.29

P.33

P.26

P.24

P.31 P.32

P.39 P.40

P.43 P.44

P.48

P.27 P.28

P.35

P.47

P.36

P.4 P.4P.80

P.81 P.10

P.3 P.4

P.5

P.9

P.6 P.7P.6

P.3

P.83

P.5